Evolve Business Intelligence has published a half-cooked research report on the Global Histology Equipment Market, 2021–2030. The global Histology Equipment market is projected to exhibit a CAGR of around 4.7% during the forecast period of 2022 to 2030.
Evolve Business Intelligence has recognized the following companies as the key players in the global Histology Equipment market: Leica, Roche, Thermo Fisher, Agilent, BioGenex, Sakura Finetek, Intelsint, and Biocare
The global Histology Equipment market is projected to be valued at $7.93 Billion by 2030, recording a CAGR of around 4.7% during the forecast period. Histology equipment is used in the examination of tissue samples. These instruments extract and prepare samples for analysis, and are typically used to diagnose cancerous or other diseased cells, which can be caused by viruses, bacteria, or other pathogens. The machines use a variety of methods to examine samples including microscopes, cell counters, and spectrometers.
The global Histology equipment market is anticipated to see a moderate effect from the COVID-19 pandemic. The healthcare sector as a whole will likely not be disrupted by the pandemic, since it has been identified as an essential service by the government across the world. Furthermore, during the COVID-19 crisis, researchers and medical experts are increasingly focusing on understanding pathological changes in various organs of patients with COVID-19. Although COVID-19 primarily affects the respiratory and immune systems, it could also hurt other systems, including the urinary and digestive tracts, cardiovascular systems, reproductive systems, and integumentary systems.
The global Histology Equipment market has been segmented based on the Type, Application, and region.
By Type, the Histology Equipment market is segmented based on Slide-staining Systems, Scanners, and Tissue-processing Systems. The Slide-staining Systems segment dominates the market due to different technological advancements, providing better insights for diagnosing various bacterial, fungal, viral, and parasitic diseases
Based on Application, the Histology Equipment market is segmented based on Hospitals, Diagnostic Centers, and Research Laboratories. The Diagnostic Centers segment is anticipated to hold the largest market owing to several factors, such as the rising number of people seeking referrals from diagnostic centers and the increase in private investment in the diagnostics sector.
The Histology Equipment market is divided into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. The North American region is projected to dominate the global Histology Equipment market. Stringent government regulations, large-scale research units, and awareness about drug safety in North America are key factors that may potentially increase the number of drugs manufactured there. The Asia-Pacific region is expected to grow at the highest CAGR over the forecast period. due to the rapid growth in the healthcare and medical sector in the region. The European countries have been experiencing consistent growth in the Histology Equipment market over the past few years. The increasing incidence of cancer and cardiovascular diseases in European countries has fueled the demand for diagnostic and histological equipment. With technological advancements in equipment, doctors can diagnose diseases without invasive tests. The Middle East and Africa are regions with enormous potential for investment both in the healthcare sector as well as in the medical research industry. Several factors have been identified that have contributed to this growth, including an increase in the population and rapidly developing healthcare infrastructure.